FUNCtion ALS: Aiming to Restore UNC13A Function in People Living With ALS

NCT07674667 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: TRCN-1023
OTHER: Placebo

Sponsor

Trace Neuroscience, Inc.